vs

Side-by-side financial comparison of Sphere 3D Corp. (ANY) and NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC). Click either name above to swap in a different company.

NEUROONE MEDICAL TECHNOLOGIES Corp is the larger business by last-quarter revenue ($2.9M vs $2.7M, roughly 1.1× Sphere 3D Corp.). On growth, Sphere 3D Corp. posted the faster year-over-year revenue change (3.1% vs -11.7%). NEUROONE MEDICAL TECHNOLOGIES Corp produced more free cash flow last quarter ($-3.2M vs $-23.6M). Over the past eight quarters, NEUROONE MEDICAL TECHNOLOGIES Corp's revenue compounded faster (44.9% CAGR vs -37.4%).

Sphere 3D Corp is a global technology company specializing in cloud computing, data management, and virtualization solutions. It delivers enterprise-grade products and services tailored for small to medium-sized businesses, large enterprise clients, and public sector entities, focusing on optimizing IT infrastructure efficiency and cutting operational costs for end users.

NeuroOne Medical Technologies Corp is a medical technology company specializing in the development and commercialization of diagnostic and therapeutic neurological devices for conditions including epilepsy, movement disorders, and chronic pain. Its core products include minimally invasive cortical monitoring electrodes and neurostimulation systems, primarily serving neurology and neurosurgical care providers across North America.

ANY vs NMTC — Head-to-Head

Bigger by revenue
NMTC
NMTC
1.1× larger
NMTC
$2.9M
$2.7M
ANY
Growing faster (revenue YoY)
ANY
ANY
+14.8% gap
ANY
3.1%
-11.7%
NMTC
More free cash flow
NMTC
NMTC
$20.5M more FCF
NMTC
$-3.2M
$-23.6M
ANY
Faster 2-yr revenue CAGR
NMTC
NMTC
Annualised
NMTC
44.9%
-37.4%
ANY

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ANY
ANY
NMTC
NMTC
Revenue
$2.7M
$2.9M
Net Profit
$-1.4M
Gross Margin
54.2%
Operating Margin
-372.7%
-59.0%
Net Margin
-49.7%
Revenue YoY
3.1%
-11.7%
Net Profit YoY
-180.5%
EPS (diluted)
$-6.96
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANY
ANY
NMTC
NMTC
Q4 25
$2.7M
$2.9M
Q3 25
$2.6M
$2.7M
Q2 25
$3.0M
$1.7M
Q1 25
$2.8M
$1.4M
Q4 24
$2.6M
$3.3M
Q3 24
$2.4M
$272.3K
Q2 24
$4.7M
$825.8K
Q1 24
$6.9M
$1.4M
Net Profit
ANY
ANY
NMTC
NMTC
Q4 25
$-1.4M
Q3 25
$-4.2M
$-1.6M
Q2 25
$1.7M
$-1.5M
Q1 25
$-8.8M
$-2.3M
Q4 24
$1.8M
Q3 24
$104.0K
Q2 24
$2.1M
$-2.8M
Q1 24
$-4.5M
$-2.9M
Gross Margin
ANY
ANY
NMTC
NMTC
Q4 25
54.2%
Q3 25
25.4%
55.8%
Q2 25
23.8%
53.9%
Q1 25
22.1%
55.6%
Q4 24
58.9%
Q3 24
-16.0%
51.8%
Q2 24
15.2%
34.1%
Q1 24
38.0%
28.3%
Operating Margin
ANY
ANY
NMTC
NMTC
Q4 25
-372.7%
-59.0%
Q3 25
-153.8%
-50.0%
Q2 25
-87.0%
-111.2%
Q1 25
-184.2%
-193.3%
Q4 24
-328.7%
52.3%
Q3 24
-218.8%
Q2 24
-122.4%
-338.3%
Q1 24
-26.9%
-209.5%
Net Margin
ANY
ANY
NMTC
NMTC
Q4 25
-49.7%
Q3 25
-162.0%
-59.1%
Q2 25
55.2%
-88.5%
Q1 25
-311.9%
-163.8%
Q4 24
54.5%
Q3 24
4.4%
Q2 24
45.5%
-335.1%
Q1 24
-64.5%
-207.3%
EPS (diluted)
ANY
ANY
NMTC
NMTC
Q4 25
$-6.96
$-0.03
Q3 25
$-0.15
$-0.05
Q2 25
$0.06
$-0.03
Q1 25
$-0.32
$-0.07
Q4 24
$-4.62
$0.06
Q3 24
$0.01
Q2 24
$0.10
$-0.10
Q1 24
$-0.27
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANY
ANY
NMTC
NMTC
Cash + ST InvestmentsLiquidity on hand
$3.7M
$3.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$23.3M
$6.4M
Total Assets
$25.1M
$8.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANY
ANY
NMTC
NMTC
Q4 25
$3.7M
$3.6M
Q3 25
$5.3M
$6.6M
Q2 25
$4.7M
$8.0M
Q1 25
$2.8M
$1.3M
Q4 24
$5.4M
$1.1M
Q3 24
$5.0M
$1.5M
Q2 24
$4.3M
$1.6M
Q1 24
$9.3M
$2.4M
Stockholders' Equity
ANY
ANY
NMTC
NMTC
Q4 25
$23.3M
$6.4M
Q3 25
$29.5M
$7.1M
Q2 25
$32.7M
$8.2M
Q1 25
$30.7M
$1.1M
Q4 24
$39.3M
$2.9M
Q3 24
$35.8M
$822.0K
Q2 24
$33.4M
$3.0M
Q1 24
$27.5M
$3.9M
Total Assets
ANY
ANY
NMTC
NMTC
Q4 25
$25.1M
$8.6M
Q3 25
$31.1M
$10.8M
Q2 25
$34.4M
$10.8M
Q1 25
$34.3M
$4.5M
Q4 24
$43.2M
$6.5M
Q3 24
$44.3M
$5.4M
Q2 24
$44.0M
$4.9M
Q1 24
$42.0M
$5.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANY
ANY
NMTC
NMTC
Operating Cash FlowLast quarter
$-16.1M
$-3.1M
Free Cash FlowOCF − Capex
$-23.6M
$-3.2M
FCF MarginFCF / Revenue
-867.3%
-109.1%
Capex IntensityCapex / Revenue
275.4%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANY
ANY
NMTC
NMTC
Q4 25
$-16.1M
$-3.1M
Q3 25
$-3.5M
$-1.5M
Q2 25
$-5.8M
$-1.5M
Q1 25
$-4.1M
$-56.1K
Q4 24
$-4.6M
$208.0K
Q3 24
$290.0K
$-11.0M
Q2 24
$-3.3M
$-2.4M
Q1 24
$-58.0K
$-2.2M
Free Cash Flow
ANY
ANY
NMTC
NMTC
Q4 25
$-23.6M
$-3.2M
Q3 25
$-5.7M
Q2 25
$-6.0M
$-1.5M
Q1 25
$-5.1M
Q4 24
$-13.5M
$183.6K
Q3 24
$-4.3M
$-11.1M
Q2 24
$-2.4M
Q1 24
$-2.2M
FCF Margin
ANY
ANY
NMTC
NMTC
Q4 25
-867.3%
-109.1%
Q3 25
-218.7%
Q2 25
-200.5%
-89.0%
Q1 25
-181.2%
Q4 24
-511.9%
5.6%
Q3 24
-184.4%
-4088.4%
Q2 24
-287.6%
Q1 24
-160.2%
Capex Intensity
ANY
ANY
NMTC
NMTC
Q4 25
275.4%
1.4%
Q3 25
86.5%
Q2 25
6.6%
2.8%
Q1 25
36.4%
Q4 24
338.7%
0.7%
Q3 24
196.7%
44.1%
Q2 24
0.0%
1.8%
Q1 24
0.0%
2.3%
Cash Conversion
ANY
ANY
NMTC
NMTC
Q4 25
Q3 25
Q2 25
-3.51×
Q1 25
Q4 24
0.12×
Q3 24
2.79×
Q2 24
-1.55×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons